Novocell, a stem cell engineering company headquartered in San Diego, Calif., this week announced the launch of STEMPRO hESC SFM, a fully-defined, serum- and feeder-free media specifically formulated for the growth and expansion of human embryonic stem cells.
The product will be sold by Invitrogen under a licensing agreement with Novocell.
Accoding to the companies, STEMPRO hESC SFM is the first serum- and feeder-free media for hESCs that has been shown to maintain these cells in a genetically normal state. STEMPRO hESC SFM has been extensively tested and proven to keep hESCs pluripotent in a number of lines, including BG01, BG02, BG03, HUES9, H1, and H9.